Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Gelesis Holdings Inc (GLS)

Gelesis Holdings Inc (GLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,631
  • Shares Outstanding, K 73,333
  • Annual Sales, $ 25,770 K
  • Annual Income, $ -56,030 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.88
  • Price/Sales 0.45
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.80
  • Most Recent Earnings $-0.33 on 03/28/23
  • Next Earnings Date 05/11/23
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr N/A
See More
  • Average Estimate N/A
  • Number of Estimates N/A
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1100 +44.18%
on 03/17/23
0.2872 -44.78%
on 03/20/23
-0.0814 (-33.92%)
since 03/10/23
3-Month
0.1100 +44.18%
on 03/17/23
0.4100 -61.32%
on 01/25/23
-0.2614 (-62.24%)
since 01/10/23
52-Week
0.1100 +44.18%
on 03/17/23
5.7100 -97.22%
on 04/11/22
-5.3614 (-97.13%)
since 04/08/22

Most Recent Stories

More News
Gelesis Reports Fourth Quarter and Full Year 2022 Results

Gelesis Holdings, Inc. (NYSE: GLS) (“Gelesis” or the “Company”), the maker of Plenity for weight management, today reported financial results for the year ended December 31, 2022. Plenity is...

GLS : 0.1586 (+0.38%)
Gelesis to Participate in the 25th Annual ICR Conference

Gelesis (NYSE: GLS), the maker of Plenity for weight management, today announced that the Company will participate in the 25 th Annual ICR Conference in Orlando, Florida on Monday, January 9, 2023.

GLS : 0.1586 (+0.38%)
PureTech Provides End of Year Report on Key Progress

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases, today...

PRTC : 20.83 (+2.36%)
PRTC.LN : 155.400 (+1.83%)
KRTX : 329.83 (+0.03%)
GLS : 0.1586 (+0.38%)
VOR : 0.8048 (-4.17%)
AKLI : 0.4320 (-0.62%)
BIIB : 173.79 (-0.12%)
Gelesis Reports Upcoming Participation in Wolfe Research’s Annual Consumer Growth Conference

Gelesis Holdings, Inc. (NYSE: GLS) (“Gelesis” or the “Company”), the maker of Plenity for weight management, today announced that its Chief Operating & Commercial Officer, David Pass, Pharm.D.,...

GLS : 0.1586 (+0.38%)
Gelesis Receives Notice of NYSE Market Capitalization Listing Rule Non-Compliance

Gelesis Holdings Inc. (NYSE: GLS) (“Gelesis” or the “Company”) today noted that on November 16, 2022, the Company received a notification letter (the “Notice”) from the New York Stock Exchange...

GLS : 0.1586 (+0.38%)
Gelesis Reports Third Quarter 2022 Results

Gelesis Holdings, Inc. (NYSE: GLS) (“Gelesis” or the “Company”), the maker of Plenity for weight management, today reported financial results for the third quarter of 2022. Plenity is a novel...

GLS : 0.1586 (+0.38%)
Gelesis to Report Third Quarter 2022 Financial Results on November 14, 2022

Gelesis Holdings, Inc. (NYSE:GLS) (“Gelesis” or the “Company”), the maker of Plenity ® for weight management, today announced that the Company will report financial results for the third quarter...

GLS : 0.1586 (+0.38%)
Gelesis Receives Notice of NYSE Trading Share Price Listing Rule Non-Compliance

Gelesis Holdings Inc. (NYSE: GLS) (“Gelesis” or the “Company”) today noted that the Company received a notification letter from the New York Stock Exchange (the “NYSE”) advising that because...

GLS : 0.1586 (+0.38%)
Data Presented at Obesity Week Demonstrate that Gelesis Investigational Clinical-Stage Oral Superabsorbent Hydrogel Gel-B Preferentially Enhances the Growth of Akkermansia muciniphila in Preclinical Models Compared to Prebiotics

Gelesis Holdings Inc. (NYSE: GLS) (“Gelesis” or the “Company”) the maker of Plenity for weight management, today released new data at Obesity Week in San Diego. The study investigated how an oral...

GLS : 0.1586 (+0.38%)
Dr. Frank Greenway to Present Data from the LIGHT-UP Study with Gelesis’ Oral Hydrogel Treatment GS200 at Obesity Week

Gelesis Holdings Inc. (NYSE: GLS) (“Gelesis” or the “Company”) the maker of Plenity for weight management, today announced Dr. Frank Greenway will give an oral presentation at Obesity Week in San...

GLS : 0.1586 (+0.38%)

Business Summary

Gelesis is a consumer-centered biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Gelesis, formerly known as Capstar Special Purpose Acquisition Corp., is based in BOSTON.

See More

Key Turning Points

3rd Resistance Point 0.1827
2nd Resistance Point 0.1725
1st Resistance Point 0.1655
Last Price 0.1586
1st Support Level 0.1483
2nd Support Level 0.1381
3rd Support Level 0.1311

See More

52-Week High 5.7100
Fibonacci 61.8% 3.5708
Fibonacci 50% 2.9100
Fibonacci 38.2% 2.2492
Last Price 0.1586
52-Week Low 0.1100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar